Erratum: Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 38 (15978-15983) DOI: 10.1073/pnas.1108558108);Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 38, 2011, Pages 15978-15983

  Zasloff, Michael ^a   Adams, A Paige ^b   Beckerman, Bernard ^c   Campbell, Ann ^d   Han, Ziying ^e   Luijten, Erik ^c   Meza, Isaura ^f   Julander, Justin ^g   Mishra, Abhijit ^h   Qu, Wei ^c   Taylor, John M ^d   Weaver, Scott C ^b   Wong, Gerard C L ^h  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Northwestern University   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^g UTAH STATE UNIVERSITY   (United States)

^h University of California   (United States)

Author keywords

Dengue virus; Eastern equine encephalitis virus; Hepatitis B virus; Innate immunity; Yellow fever virus

Indexed keywords

PLACEBO; RIBAVIRIN; SQUALAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENGUE; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; INTRACELLULAR MEMBRANE; MOUSE; NONHUMAN; PETROMYZON; PRIORITY JOURNAL; SINGLE DRUG DOSE; SQUALUS; SURFACE CHARGE; VIRUS ENVELOPE; VIRUS REPLICATION; YELLOW FEVER FLAVIVIRUS;

DENGUE VIRUS; EASTERN EQUINE ENCEPHALITIS VIRUS; HEPATITIS B VIRUS; PETROMYZON MARINUS; SQUALIDAE; SQUALUS ACANTHIAS; YELLOW FEVER VIRUS;

EID: 80053145985     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1115667108     Document Type: Erratum

References (61)

1. Moore KS, et al. (1993) Squalamine: An aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 90:1354-1358. (Pubitemid 23058170)
2. Wehrli SL, Moore KS, Roder H, Durell S, Zasloff M (1993) Structure of the novel steroidal antibiotic squalamine determined by two-dimensional NMR spectroscopy. Steroids 58:370-378.
3. Yun SS, Li W (2007) Identification of squalamine in the plasma membrane of white blood cells in the sea lamprey, Petromyzon marinus. J Lipid Res 48:2579-2586.
4. Li D, Williams JI, Pietras RJ (2002) Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene 21:2805-2814. (Pubitemid 34499377)
5. Williams JI, et al. (2001) Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies. Clin Cancer Res 7:724-733. (Pubitemid 32707999)
6. Schiller JH, Bittner G (1999) Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: Effects on tumor neovascularization. Clin Cancer Res 5:4287-4294. (Pubitemid 30013817)
7. Yin M, Gentili C, Koyama E, Zasloff M, Pacifici M (2002) Antiangiogenic treatment delays chondrocyte maturation and bone formation during limb skeletogenesis. J Bone Miner Res 17:56-65. (Pubitemid 33150997)
8. Genaidy M, et al. (2002) Effect of squalamine on iris neovascularization in monkeys. Retina 22:772-778. (Pubitemid 35462508)
9. Higgins RD, Sanders RJ, Yan Y, Zasloff M, Williams JI (2000) Squalamine improves retinal neovascularization. Invest Ophthalmol Vis Sci 41:1507-1512. (Pubitemid 30261877)
10. Higgins RD, Yan Y, Geng Y, Zasloff M, Williams JI (2004) Regression of retinopathy by squalamine in a mouse model. Pediatr Res 56:144-149. (Pubitemid 38808556)
11. Sills AK, Jr., et al. (1998) Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res 58:2784-2792.
12. Yeung T, et al. (2008) Membrane phosphatidylserine regulates surface charge and protein localization. Science 319:210-213.
13. Sumioka A, Yan D, Tomita S (2010) TARP phosphorylation regulates synaptic AMPA receptors through lipid bilayers. Neuron 66:755-767.
14. Alexander RT, et al. (2011) Membrane surface charge dictates the structure and function of the epithelial Na+/H+ exchanger. EMBO J 30:679-691.
15. Selinsky BS, Smith R, Frangiosi A, Vonbaur B, Pedersen L (2000) Squalamine is not a proton ionophore. Biochim Biophys Acta 1464:135-141. (Pubitemid 30110524)
16. Selinsky BS, et al. (1998) The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles. Biochim Biophys Acta 1370:218-234. (Pubitemid 28183974)
17. Hao D, et al. (2003) A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor. Clin Cancer Res 9:2465-2471. (Pubitemid 36842085)
18. Bhargava P, et al. (2001) A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers. Clin Cancer Res 7:3912-3919. (Pubitemid 34044608)
19. Herbst RS, et al. (2003) A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Clin Cancer Res 9:4108-4115. (Pubitemid 37204027)
20. Pelkmans L, et al. (2005) Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436:78-86. (Pubitemid 40966188)
21. Pelkmans L, Helenius A (2003) Insider information: What viruses tell us about endocytosis. Curr Opin Cell Biol 15:414-422. (Pubitemid 36928043)
22. Zamudio-Meza H, Castillo-Alvarez A, González-Bonilla C, Meza I (2009) Cross-talk between Rac1 and Cdc42 GTPases regulates formation of filopodia required for dengue virus type-2 entry into HMEC-1 cells. J Gen Virol 90:2902-2911.
23. Harmon B, Campbell N, Ratner L (2010) Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog 6:e1000956.
24. Mercer J, Helenius A (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. (Pubitemid 351590666)
25. Ahola T, Lampio A, Auvinen P, Kääriäinen L (1999) Semliki Forest virus mRNA capping enzyme requires association with anionic membrane phospholipids for activity. EMBO J 18:3164-3172. (Pubitemid 29255624)
26. Chukkapalli V, Hogue IB, Boyko V, Hu WS, Ono A (2008) Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol- (4,5)-bisphosphate is essential for efficient gag membrane binding. J Virol 82:2405-2417. (Pubitemid 351293541)
27. Chukkapalli V, Oh SJ, Ono A (2010) Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc Natl Acad Sci USA 107:1600-1605.
28. Stansell E, et al. (2007) Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J Virol 81:8977-8988. (Pubitemid 47311441)
29. Agirre A, Barco A, Carrasco L, Nieva JL (2002) Viroporin-mediated membrane permeabilization. Pore formation by nonstructural poliovirus 2B protein. J Biol Chem 277:40434-40441. (Pubitemid 35215619)
30. Coil DA, Miller AD (2004) Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 78:10920-10926. (Pubitemid 39299632)
31. Coil DA, Miller AD (2005) Enhancement of enveloped virus entry by phosphatidylserine. J Virol 79:11496-11500. (Pubitemid 41170690)
32. Coil DA, Miller AD (2005) Phosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors. Retrovirology 2:49.
33. Soares MM, King SW, Thorpe PE (2008) Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat Med 14:1357-1362.
34. Liang H, Whited G, Nguyen C, Stucky GD (2007) The directed cooperative assembly of proteorhodopsin into 2D and 3D polarized arrays. Proc Natl Acad Sci USA 104:8212-8217. (Pubitemid 47175467)
35. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
36. Vance JE, Steenbergen R (2005) Metabolism and functions of phosphatidylserine. Prog Lipid Res 44:207-234. (Pubitemid 40973811)
37. Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189:1411-1418. (Pubitemid 38543590)
38. Wang JL, et al. (2010) Roles of small GTPase Rac1 in the regulation of actin cytoskeleton during dengue virus infection. PLoS Negl Trop Dis 4:e809.
39. Stauffer F, et al. (2008) Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering. Mol Membr Biol 25:128-138. (Pubitemid 351317504)
40. Taylor JM, Han Z (2010) Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus. PLoS One 5:e15784.
41. Tesh RB, et al. (2001) Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. J Infect Dis 183:1431-1436.
42. Paessler S, et al. (2004) The hamster as an animal model for eastern equine encephalitis - and its use in studies of virus entrance into the brain. J Infect Dis 189: 2072-2076. (Pubitemid 38692288)
43. Cavanaugh VJ, Deng Y, Birkenbach MP, Slater JS, Campbell AE (2003) Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J Virol 77:1703-1717. (Pubitemid 36109982)
44. Sacher T, et al. (2008) The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3:263-272. (Pubitemid 351494715)
45. Julander JG, Shafer K, Smee DF, Morrey JD, Furuta Y (2009) Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrob Agents Chemother 53:202-209.
46. Cardin RD, et al. (2009) Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection. Virol J 6:214.
47. Xiao SY, Zhang H, Guzman H, Tesh RB (2001) Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology. J Infect Dis 183:1437-1444. (Pubitemid 32417695)
48. Julander JG, Morrey JD, Blatt LM, Shafer K, Sidwell RW (2007) Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Res 73:140-146. (Pubitemid 46135771)
49. Sbrana E, et al. (2004) Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease. Am J Trop Med Hyg 71:306-312. (Pubitemid 39223506)
50. Wang E, et al. (2007) Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine 25:7573-7581. (Pubitemid 47503491)
51. Arrigo NC, Watts DM, Frolov I, Weaver SC (2008) Experimental infection of Aedes sollicitans and Aedes taeniorhynchus with two chimeric Sindbis/Eastern equine encephalitis virus vaccine candidates. Am J Trop Med Hyg 78:93-97. (Pubitemid 351844501)
52. Vogel P, Kell WM, Fritz DL, Parker MD, Schoepp RJ (2005) Early events in the pathogenesis of eastern equine encephalitis virus in mice. Am J Pathol 166:159-171. (Pubitemid 40051669)
53. Zasloff M (1997) US Patent 6,143,738.
54. Villarreal LP (2005) Viruses and the Evolution of Life (ASM Press, Washington, DC).
55. Adelman MK, Schluter SF, Marchalonis JJ (2004) The natural antibody repertoire of sharks and humans recognizes the potential universe of antigens. Protein J 23:103-118.
56. Venkatesh B, et al. (2007) Survey sequencing and comparative analysis of the elephant shark (Callorhinchus milii) genome. PLoS Biol 5:e101.
57. Basta HA, Cleveland SB, Clinton RA, Dimitrov AG, McClure MA (2009) Evolution of teleost fish retroviruses: Characterization of new retroviruses with cellular genes. J Virol 83:10152-10162.
58. Wolf MC, et al. (2010) A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci USA 107:3157-3162.
59. Pietras RJ, Weinberg OK (2005) Antiangiogenic steroids in human cancer therapy. Evid Based Complement Alternat Med 2:49-57. (Pubitemid 41399514)
60. Connolly B, Desai A, Garcia CA, Thomas E, Gast MJ (2006) Squalamine lactate for exudative age-related macular degeneration. Ophthalmol Clin North Am 19:381-391. (Pubitemid 44403943)
61. Zhang XH, et al. (1998) Synthesis of squalamine utilizing a readily accessible spermidine equivalent. J Org Chem 63:8599-8603.